This protective order is a routine procedural step in patent litigation. Monitor for future substantive rulings (e.g., claim construction, summary judgment, trial) that could affect Novo Nordisk's semaglutide-related IP. No immediate trading implications.
Price Chart
Executive Summary
This is a routine stipulated protective order entered in a patent litigation case between Novo Nordisk and Aios Inc. (Fella Health). The order governs the handling of confidential discovery materials and contains no substantive ruling on the merits, damages, or injunctive relief. It is a procedural document with no financial or operational impact on Novo Nordisk.
Court Ruling Details
Key Facts
- Case: Novo Nordisk A/S et al v. Aios Inc. d/b/a Fella Health et al., No. 4:25-cv-06560-YGR (N.D. Cal.)
- Document 78 is a stipulated protective order entered on September 23, 2026
- The order governs confidentiality designations for discovery materials, including a prosecution bar related to semaglutide patents
- No substantive ruling on patent validity, infringement, damages, or injunctive relief was issued
- The case remains in active litigation with no final judgment or material event
Financial Impact
No financial impact — the order is procedural and does not award damages, impose an injunction, or resolve any claims
Risk Factors
- No material risk identified from this filing — the case is in early stages and no substantive ruling has been made
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-b150ec9871-NVO |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $39.13 | awaiting T+20 | — | $38.67 (−1.18%) |
Oct 26, 2026 2d ago | Court Ruling | $38.59 | awaiting T+20 | — | $38.67 (+0.21%) |
Oct 19, 2026 8d ago | 6-K | $38.42 | awaiting T+20 | — | $38.67 (+0.65%) |
Oct 13, 2026 14d ago | 6-K | $38.06 | awaiting T+20 | — | $38.67 (+1.60%) |
Oct 6, 2026 21d ago | 6-K | $37.53 | awaiting T+20 | — | $38.67 (+3.04%) |
Sep 28, 2026 29d ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $38.67 (−0.10%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $38.67 (+0.13%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $38.67 (−2.84%) |
Sep 17, 2026 5w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $38.67 (−10.47%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $38.67 (−9.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers